Act Capital Management, LLC Syros Pharmaceuticals, Inc. Transaction History

Act Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	BUY	$1.02 - $3.8 $13,770 - $51,300	13,500 Added 62.79%	35,000 $42,000
Q4 2021 Feb 03, 2022	SELL	$3.26 - $4.66 $101,060 - $144,460	-31,000 Reduced 59.05%	21,500 $70,000
Q2 2021 Aug 16, 2021	BUY	$5.01 - $7.48 $263,025 - $392,700	52,500 New	52,500 $287,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $4.86M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Act Capital Management, LLC with notifications on news.